unknown
Stage
2
Investors
About
BioVex is a biotechnology company headquartered in Thousand Oaks, California, developing and commercializing biologic therapies, including proprietary vaccine platforms OncoVEX and ImmunoVEX, for the treatment of cancer and prevention of infectious diseases.
Explore BioVex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.